Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 27 (5) , 542-551
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010The Journal of Heart and Lung Transplantation, 2010
- Attenuation of Transplant Arteriosclerosis With Clopidogrel Is Associated With a Reduction of Infiltrating Dendritic Cells and Macrophages in Murine Aortic AllograftsTransplantation, 2009
- Allograft Vasculopathy Versus AtherosclerosisCirculation Research, 2006
- Clopidogrel reduces the development of transplant arteriosclerosisThe Journal of Thoracic and Cardiovascular Surgery, 2006
- Intravascular Ultrasound Evidence of Angiographically Silent Progression in Coronary Atherosclerosis Predicts Long-Term Morbidity and Mortality After Cardiac TransplantationJACC, 2005
- Platelet activation in heart transplant recipientsClinical Transplantation, 2004
- Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant VasculopathyCirculation, 2000
- Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Cyclosporine A enhances platelet aggregationKidney International, 1987
- THROMBOEMBOLIC COMPLICATIONS AND HAEMOSTATIC CHANGES IN CYCLOSPORIN-TREATED CADAVERIC KIDNEY ALLOGRAFT RECIPIENTSThe Lancet, 1985